Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option

• Main Authors: Manuel Kraft (Author), Antonius Büscher (Author), Felix Wiedmann (Author), Yannick L'hoste (Author), Walter E. Haefeli (Author), Norbert Frey (Author), Hugo A. Katus (Author), Constanze Schmidt (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Atrial fibrillation (AF) is the most common sustained arrhythmia with a prevalence of up to 4% and an upwards trend due to demographic changes. It is associated with an increase in mortality and stroke incidences. While stroke risk can be significantly reduced through anticoagulant therapy, adequate...